Therapy News and Research

RSS

UQDI reveals that Anisina drug can kill melanoma cells

US-Australian drug discovery company, Novogen, today announced that studies conducted at The University of Queensland Diamantina Institute revealed that experimental drug, Anisina, killed melanoma cells irrespective of their mutational status.

9 Apr 2015

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for early-stage invasive breast cancer.

9 Apr 2015

Study suggests that pancreatic cancers harbor genetic alterations

A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women.

9 Apr 2015

University of York scientists use low temperature plasmas to treat prostate cancer

Scientists at the University of York have discovered a potential new treatment for prostate cancer using low temperature plasmas (LTPs).

9 Apr 2015

UAB scientists create alternative to the use of viruses in gene therapy

A team of scientists from the Institute for Biotechnology and Biomedicine at the UAB has produced an alternative to the use of viruses in gene therapy. The researchers synthesised nanoparticles which act as artificial viruses, capable of surrounding DNA fragments and releasing them as therapeutic agents, with no biological risk, into the interior of the cells.

9 Apr 2015

Researchers link loss of WAVE1 gene to lethal form of prostate cancer

Researchers at Upstate Medical University and Harvard University have linked the loss of key gene, WAVE1, to a lethal form of prostate cancer, according to a study published in the journal Oncotarget.

9 Apr 2015

Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

9 Apr 2015

Study finds no strong link between lung cancer risk and reproductive history variables

The Women's Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer.

9 Apr 2015

New study describes economic consequences of using T2Candida Panel for detection of candidemia

A new study describes a model that estimates the economic consequences of using the T2Candida Panel (a novel diagnostic product that provides Candida detection) as an adjunct to the current blood culture-based diagnostic strategy in a high-risk hospital patient cohort.

9 Apr 2015

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Huntington's disease is an hereditary disorder of the nervous system caused by a faulty gene on chromosome four. The faulty gene leads to nerve damage in the area of the brain resulting in gradual physical, mental and emotional changes. Those born to a parent with Huntington's disease have a 50:50 chance of developing it, and there is currently no cure.

9 Apr 2015

Short-term balance program can reduce risk of falling in older population

Falling is bad news for senior citizens—oftentimes resulting in life-changing injuries, such as hip fractures and head traumas, and an increased risk of early death. New research findings at University of the Sciences into how and why seniors fall may provide healthcare providers with insight on improved balance and strength-training strategies to prevent tumbles by the elderly.

8 Apr 2015

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards.

8 Apr 2015

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Patients hospitalized with advanced cirrhosis, a chronic and degenerative disease of the liver, are at increased risk of death. The tools currently used to assess that risk are limited in predicting which patients will need a liver transplant and which will be healthy enough to survive transplantation.

8 Apr 2015

Frost & Sullivan forecasts growth of global healthcare market

The healthcare industry is entangled in a transitory phase in which therapeutics, devices, products and services are sold into traditional care settings that are unable to keep up with the requirements placed upon it by changing demographics and consumer needs. At the same time, opportunities for new services and care, such as ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams despite having the promise to increase healthcare delivery efficiency and reduce long term costs.

8 Apr 2015

Qualcomm Life launches HealthyCircles Mobile app

Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., launched the HealthyCircles Mobile application, a secure, medical-grade mobile care solution that provides a frictionless on-the-go care experience for consumers via their mobile device.

8 Apr 2015

Two case studies provide potential new avenue for treatment of kidney cancer

UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.

8 Apr 2015

Harry Folk speaks about successful throat cancer treatment received at St. Luke’s Cancer Center

It’s been nine years since Harry Folk of Palmer Township had a scare with throat cancer. He is able to talk about his journey, literally, thanks to the treatment he received at St. Luke’s. The treatment plan recommended by his cancer team not only removed his cancer, but preserved his voice and ability to swallow without difficulty.

8 Apr 2015

St. Luke’s Cancer Center offers new Phase II oncolytic viral therapy clinical trial for advanced melanoma

St. Luke’s Cancer Center is a leader in offering clinical trials for patients with melanoma, the most unusual type of skin cancer and also the most deadly. Physicians such as Sanjiv Agarwala, MD, Chief of Medical Oncology and Hematology for St. Luke’s University Health Network and an internationally recognized melanoma specialist, are committed to bringing the most promising studies to the Lehigh Valley.

8 Apr 2015

Proton Partners International to open three Proton Beam Therapy centres in UK

The UK is to get its first three Proton Beam Therapy centres, marking a significant breakthrough in the provision of cancer treatment.

8 Apr 2015

Impulse control disorders do not promote cognitive decline in PD

Impulse control disorders in patients with Parkinson’s disease are not associated with more marked impairment of cognitive function, researchers report.

7 Apr 2015

Therapy News and Research

UQDI reveals that Anisina drug can kill melanoma cells

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Study suggests that pancreatic cancers harbor genetic alterations

University of York scientists use low temperature plasmas to treat prostate cancer

UAB scientists create alternative to the use of viruses in gene therapy

Researchers link loss of WAVE1 gene to lethal form of prostate cancer

Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

Study finds no strong link between lung cancer risk and reproductive history variables

New study describes economic consequences of using T2Candida Panel for detection of candidemia

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Short-term balance program can reduce risk of falling in older population

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Frost & Sullivan forecasts growth of global healthcare market

Qualcomm Life launches HealthyCircles Mobile app

Two case studies provide potential new avenue for treatment of kidney cancer

Harry Folk speaks about successful throat cancer treatment received at St. Luke’s Cancer Center

St. Luke’s Cancer Center offers new Phase II oncolytic viral therapy clinical trial for advanced melanoma

Proton Partners International to open three Proton Beam Therapy centres in UK

Impulse control disorders do not promote cognitive decline in PD

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News